Executive Summary

Oct 2019
PROSPECTS
Performance improves but sales still declining in cough, cold and allergy (hay fever) remedies

Cough, cold and allergy (hay fever) remedies continued to decline in 2019, albeit at a slightly slower rate than in the two previous years. The category continued to suffer at the hands of a number of factors, including the preference among French consumers for prescribed and reimbursed products.

After pharyngeal preparations and codeine-based products, now it is nasal sprays in the line of fire

Cough, cold and allergy (hay fever) remedies seems to be stumbling from one ingredient-based crisis to another. Firstly, pharyngeal preparations were under pressure, with the reverse switch to prescription status of flurbiprofen, the active ingredient in Reckitt Benckiser's Strefen.

Antihistamines/allergy remedies (systemic) enjoys another year of dynamic growth

The only product area seeing dynamic current value growth in recent years, including 2019, was antihistamines/allergy remedies (systemic). These products have been helped by falling rainfall levels in winter and spring, with no or little rain usually meaning more pollen and rising levels of people suffering from allergic reactions.

COMPETITIVE LANDSCAPE
Leader Solinest continues to grow through its Ricola brand

After having become the leading player a year earlier in 2018, Solinest continued to lead cough, cold and allergy (hay fever) remedies with the Ricola medicated confectionery brand in 2019. It also continued to perform well in 2019, with sales and share growth helped by its introduction of two new variants: Honey Sage and Echinacea Honey Lemon.

GSK’s Cetirizin Sandoz records strong growth in 2019

In 2019, some of the most dynamic brands were to be found in antihistamines/allergy remedies, notably cetirizine-based products such as Cetirizin Sandoz, Zyrtecset and other generics. In nasal sprays, growth drivers are essential oil-based brands such as ProRhinel Extra Eucalyptus by GlaxoSmithKline, Phytosun Arôms from Omega Pharma and Pranarôm from Pranarôm.

Flurbiprofen switched to prescription status

In 2019, Reckitt Benckiser’s Strefen brand was hit by the switch to prescription status of the product’s active ingredient flurbiprofen. This switch came as the country's medicines agency ANSM warned of serious adverse events related to certain NSAIDs over a number of years.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Cough, Cold and Allergy (Hay Fever) Remedies in France

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in France with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in France, our research will save you time and money while empowering you to make informed, profitable decisions.

The Cough, Cold and Allergy (Hay Fever) Remedies in France market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in France?
  • What are the major brands in France?
  • What is the impact of influenza vaccinations on the sales of cough and cold products?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Cough, Cold and Allergy (Hay Fever) Remedies in France - Category analysis

HEADLINES

PROSPECTS

Performance improves but sales still declining in cough, cold and allergy (hay fever) remedies
After pharyngeal preparations and codeine-based products, now it is nasal sprays in the line of fire
Antihistamines/allergy remedies (systemic) enjoys another year of dynamic growth

COMPETITIVE LANDSCAPE

Leader Solinest continues to grow through its Ricola brand
GSK’s Cetirizin Sandoz records strong growth in 2019
Flurbiprofen switched to prescription status

CATEGORY DATA

Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2014-2019
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2019
Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2019
Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024

Consumer Health in France - Industry Overview

EXECUTIVE SUMMARY

Consumer health continues to grow despite declining self-medication levels
Reverse switches and trend towards more natural products
Sanofi continues to lead
Chemists/pharmacies continues to dominate distribution
Continued current value growth expected over the forecast period

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 8 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2014-2019
Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format: % Value 2014-2019
Table 15 Distribution of Consumer Health by Format and Category: % Value 2019
Table 16 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2018-2019

DEFINITIONS

SOURCES

Summary 2 Research Sources